Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award
PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases
All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy
Passage Bio Is Maintained at Buy by Canaccord Genuity
Passage Bio Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Passage Bio, Lowers Price Target to $13
Optimistic Outlook for Passage Bio Amid Clinical and Financial Progress: Maintains Buy Rating
Express News | Passage Bio Inc : Canaccord Genuity Cuts Target Price to $13 From $14
Passage Bio (PASG) Gets a Buy From TD Cowen
Express News | Passage Bio Inc - Files Prospectus for Offering of up to an Aggregate of $50 Mln in Shares of Common Stock
Passage Bio | 10-Q: Quarterly report
Passage Bio Unveils Updated Corporate Presentation
Express News | Passage Bio Inc: Qtrly Shr Loss $0.30
Express News | Passage Bio Inc: Robust Balance Sheet Sufficient to Deliver Meaningful Clinical Data, With Cash Runway Into Q4 2025
Passage Bio: Cash Runway Into 4Q 2025 >PASG
Passage Bio: Cash Runway Into 4Q 2025 >PASG
Express News | Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Express News | Passage Bio Q1 Income From Operations USD -18.05 Million
Express News | Passage Bio Q1 Net Income USD -16.711 Million
Passage Bio 1Q Loss/Shr 30c >PASG
Passage Bio 1Q Loss/Shr 30c >PASG
Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
Analysts' Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)